HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs reduce risk of stroke, heart attack

BOSTON -- People whose cholesterol improved after one month on cholesterol-lowering drugs called statins reduced their risk of stroke and heart attack, according to research that will be presented at the American Academy of Neurologys 59th Annual Meeting in Boston, April 28 May 5, 2007.

The study enrolled 4,731 people within one to six months of having a stroke or transient ischemic attack, or mini-stroke, and with no history of heart disease. Half of the participants received the cholesterol-lowering drug atorvastatin and half received a placebo. The participants were then followed for an average of four and a half years.

For each 10-percent decrease in LDL, or low-density lipoprotein bad cholesterol, the risk of stroke was reduced by four percent and the risk of heart attack was reduced by seven percent. The average decrease in LDL cholesterol after one month on atorvastatin was 53 percent.

These findings reinforce the importance of controlling cholesterol, said study author Pierre Amarenco, MD, of Denis Diderot University in Paris, France, and Fellow member of the American Academy of Neurology. Its encouraging to see that reducing cholesterol so quickly can have positive long-term effects.

People with higher levels of HDL, or high-density lipoprotein good cholesterol, at the beginning of the study and after one month had a lower risk of stroke.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
2-May-2007


Page: 1

Related medicine news :

1. Cholesterol-lowering drugs may be useful in an influenza pandemic
2. Cholesterol-lowering drugs not associated with increased breast cancer risk
3. UIC researchers to develop new drugs to fight bioterrorism
4. Statin drugs may delay progressive artery damage in children
5. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
6. Experts call for urgent research into anti-epileptic drugs given to children
7. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
8. Antipsychotic drugs increase risk of death in older people with dementia
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
11. Panel offers guidelines on skin reactions to new class of cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic ... Frederick area economy by obtaining investment capital for emerging technology companies. SCP ... that have already resulted in more than a million dollars of capital investment ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology:
Cached News: